Cited by 732Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAdipose Tissue and Metabolism

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index; none of the 138 sources its claims cite is checked for support yet.

The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.

Open access
Crewe, Clair, An, Yu Aaron, Scherer, Philipp E.·2017·Journal of Clinical Investigation

Abstract

There are three dominant contributors to the pathogenesis of dysfunctional adipose tissue (AT) in obesity: unresolved inflammation, inappropriate extracellular matrix (ECM) remodeling and insufficient angiogenic potential. The interactions of these processes during AT expansion reflect both a linear progression as well as feed-forward mechanisms. For example, both inflammation and inadequate angiogenic remodeling can drive fibrosis, which can in turn promote migration of immune cells into adipose depots and impede further angiogenesis. Therefore, the relationship between the members of this triad is complex but important for our understanding of the pathogenesis of obesity. Here we untangle some of these intricacies to highlight the contributions of inflammation, angiogenesis, and the ECM to both "healthy" and "unhealthy" AT expansion.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that obesity-associated adipose tissue dysfunction arises from an ominous triad of unresolved inflammation, fibrosis/ECM remodeling, and impaired angiogenesis, with hypoxia and cellular senescence as key drivers. It synthesizes rodent and human evidence to distinguish early “healthy” adipose expansion from chronic pathologic remodeling.

Key findings

  • Early high-fat feeding triggers mild hypoxia that can drive adaptive angiogenesis, ECM remodeling, and balanced inflammation; chronic overnutrition leads to persistent hypoxia, fibrosis, senescence, necrotic adipocyte death, and unhealthy adipose expansion.
  • In rodents, one week of high-fat feeding can increase adipocyte triglyceride storage four-fold, double visceral adipose weight within one week, and cause macrophage infiltration within one day; over 12 weeks, adipocyte size increases three-fold in inguinal and seven-fold in epididymal fat, while dead epididymal adipocytes rise from 0.1% at one week to as much as 16% at 12 weeks.
  • HIF-1α and HIF-2α have opposing roles: HIF-1α is pro-angiogenic but also pro-fibrotic and proinflammatory and dominates in obesity, whereas HIF-2α attenuates HFD-induced inflammation; PHD1 KO mice show greater fat pad mass and impaired glucose tolerance, while adipocyte-specific PHD2 deletion produces resistance to HFD-induced obesity and improved glucose tolerance/insulin sensitivity despite elevated HIF-1α and HIF-2α.
  • Human data are conflicting: VEGF is reported as reduced in obese humans but also elevated and correlated with insulin resistance; most human studies report fibrosis in obese AT, yet some find less visceral fibrosis in diabetic or metabolically unhealthy obese subjects; about 40% of patients had elevated AT inflammation 12 months after bariatric surgery.

Methods

  • Design: narrative review, not a primary research study; no original experiments or systematic review methodology are described.
  • Data/sample: synthesizes cited rodent models (e.g., HFD feeding, ob/ob, PHD knockouts, VEGF manipulations) and human studies of obesity, insulin resistance, bariatric surgery, and adipose tissue biopsies.
  • Main analysis: conceptual integration of inflammation, ECM/fibrosis, angiogenesis, hypoxia signaling, and cellular senescence into a model of healthy versus unhealthy adipose tissue expansion, with two summary figures.

Limitations

  • Stated: the exact roles of HIF-1α and HIF-2α in adipose expansion require further study; mechanisms of pathologic angiogenesis in obesity are not fully understood; it is debated whether human adipose oxygen tension is low enough to be called hypoxic; no consensus exists on how to define fibrosis; and several key questions remain about angiogenic mechanisms, stages of expansion, depot-specific effects, and combination therapies.
  • Evident: as a narrative review, it lacks a described systematic search strategy, inclusion criteria, or quantitative synthesis, so conclusions depend on selected cited studies.
  • Evident: the human literature cited is heterogeneous and contradictory, especially for VEGF, inflammation, and fibrosis, limiting definitive translation from rodent models.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci88883

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 138 cited sources checked · 0 supported · 0 flagged

  • It may state two separate claims as one. 61
  • Probably not a substantial claim. 12
71 of 71
  • The paper relies on this without support.

    Rodent models of diet-induced and genetic obesity are sufficiently representative of human obesity-associated adipose tissue dysfunction for the review's conclusions.

    “Long-term HFF results in abnormal regulation of VEGF-A expression; not only do the VEGF-A levels decrease in the AT of obese mice and humans (13), but there is also evidence that the presence of VEGF in obese mice can block the regulation of neovascularization and vessel normalization (83).”
  • The paper relies on this without support.

    The role of cellular senescence in obesity-associated disease is not well understood.

    “Little is known about the role of cellular senescence in obesity-associated disease.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Figure describes adipose-tissue shrinkage and expansion together

    Minor

    The Figure 1 caption says the combined responses cause significant hypotrophy, or reduced tissue size, but then describes their consequence as adipose-tissue expansion.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 128 references

Cited by

Sorted by citations

See all 732

Metadata

Authors
Crewe, C., An, Y. A., & Scherer, P. E.
Corresponding author
Scherer, Philipp E.
Venue
Journal of Clinical Investigation
Published
2017-01-03
Volume
127
Issue
1
Pages
74-82
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2563017338
Cited by
732
References
128
Citations by year
2026: 76 · 2025: 70 · 2024: 92 · 2023: 95 · 2022: 102 · 2021: 89 · 2020: 79 · 2019: 53 · 2018: 51 · 2017: 21
FWCI
7.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Prevention and Research Institute of Texas (CPRIT RP140412, RP140412)
  • National Institute on Aging (P01AG051459)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK055758, P01DK088761, R01DK099110)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
adipose tissue dysfunction, obesity, adipose tissue inflammation, adipose tissue fibrosis, angiogenesis, extracellular matrix remodeling, immune cell infiltration, adipose tissue expansion, feed-forward mechanism
MeSH terms
Adipose Tissue, Animals, Fibrosis, Humans, Inflammation, Neovascularization, Physiologic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review